new indications for glp-1 drugs fda glp 1 What to know about the era of How underwriters should interpret GLP-1

GLP-1 agonists are drugs that mimic the action of GLP-1 hormone in our body

The decades of research on CR suggest that the reduction in cancer incidence in CR is facilitated by the reduction in glucose, insulin, and IGF-1 levels, which would otherwise stimulate cell growth and proliferation, and the reduction in oxidative stress and inflammation (49, 50)

2023 Apr 7;cd230023

Angermueller, C

Schedule a non-urgent appointment if you experience new or worsening anxiety symptoms, recurrent episodes of intense fear or discomfort accompanied by physical symptoms (palpitations, sweating, trembling, shortness of breath), persistent nausea or vomiting that interferes with medication adherence or nutrition, or symptoms that consistently occur in temporal relationship to tirzepatide injections